India has rejected a controversial study linking a new superbug in UK to surgeries in the country. The bug NDM-1 or New Delhi Metallo-1, said to be resistant to the most powerful antibiotics, has even been named after New Delhi. India says it's an attempt to target the flourishing medical tourism in the country where thousands of patients from the West have started coming for high quality but cheaper treatment.